Cargando…
Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine
PURPOSE: Erenumab-aooe (erenumab, Aimovig(®))—a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide (CGRP) receptor—is approved for the prevention of migraine in adults in a number of countries. The approved monthly dosage of erenumab (70 and/or 140 mg, depending on the...
Autores principales: | Mead, Jennifer, Dammerman, Ryan, Rasmussen, Soeren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354909/ https://www.ncbi.nlm.nih.gov/pubmed/32753854 http://dx.doi.org/10.2147/PPA.S248584 |
Ejemplares similares
-
Evaluating Ease of Use and Patient Safety of Dasiglucagon Hypo Pal Autoinjector for the Management of Hypoglycemia
por: Schaumleffel, Carol
Publicado: (2023) -
Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel(®) MyClic(®)) Improves Ease Of Use In Patients With Rheumatoid Arthritis
por: Rekaya, Naceur, et al.
Publicado: (2019) -
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients
por: Brand-Schieber, Elimor, et al.
Publicado: (2016) -
Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers
por: Berteau, Cecile, et al.
Publicado: (2010) -
Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population
por: Lange, Jakob, et al.
Publicado: (2015)